The prognostic significance of apical lymph node metastasis in patients with high-risk stage III colon cancer
- PMID: 35136136
- PMCID: PMC8825832
- DOI: 10.1038/s41598-022-06054-5
The prognostic significance of apical lymph node metastasis in patients with high-risk stage III colon cancer
Abstract
The effect of apical lymph node (APN) metastasis on the prognosis of colon cancer is unknown. The present study investigated the impact of APN metastasis on the prognosis of the patients with high-risk stage III colon cancer. This retrospective multi-institutional study included patients with pathological high-risk stage III colon cancer who underwent surgery between April 2009 and December 2014. Clinicopathological factors were examined by univariate and multivariate analyses to clarify independent risk factors for overall survival (OS) and relapse-free survival (RFS). A total of 185 patients were collected. The 5-year OS rates of patients with and without APN metastasis were 35.0% and 72.1%, respectively (p = 0.0014). The 5-year RFS rates of patients with and without APN metastasis was 16.2% and 57.2%, respectively (p = 0.0002). The rate of distant metastasis in patients with APN metastasis was significantly higher than that in patients without APN metastasis (68.8% vs. 36.7%, p = 0.012). The univariate analysis revealed that the differentiation, lymph node ratio, and APN metastasis were significantly associated with 5-year OS, and the preoperative CEA and CA19-9 levels and APN metastasis were significantly associated with 5-year RFS. The multivariate analysis showed that APN metastasis was an independent risk factor for 5-year OS and RFS. APN metastasis may be independently associated with the prognosis of patients with high-risk Stage III colon cancer.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int. J. Clin. Oncol. 2020;25(1):1–42. doi: 10.1007/s10147-019-01485-z. - DOI - PMC - PubMed
-
- Kawada, H., Kurita, N., Nakamura, F., Kawamura, J., Hasegawa, S., Kotake, K., Sugihara, K., Fukuhara, S., & Sakai, Y. Incorporation of apical lymph node status into the seventh edition of the tnm classification improves prediction of prognosis in stage iii colonic cancer. Br. J. Surg. 10(9):1143–1152 (2014) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
